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Abstract
Background: Hyperglycemia can impair the male reproductive system in experimental animals and in men during
reproductive age. Studies have shown that vitamin C has some good effects on male reproductive system, and
therefore vitamin C treatment could attenuate the dysfunctions in this system caused by hyperglycemia. Thus, the
objective of this work was to evaluate whether vitamin C treatment could attenuate reproductive dysfunctions in
hyperglycemic male rats.
Methods: Adult male rats were divided into 3 groups: a normoglycemic (n = 10) and two hyperglycemic (that
received a single dose of streptozotocin - 40 mg/kg BW). The two last groups (n = 10 per group) were divided
into: hyperglycemic control (Hy) and hyperglycemic + 150 mg of vitamin C (HyC), by gavage during 30
consecutive days. The normoglycemic and hyperglycemic control groups received the vehicle (water). The first day
after the treatment, the rats were anesthetized and killed to evaluate oxidative stress biomarkers (TBARS, SOD, GSHt
and GSH-Px) in the erythrocytes, body and reproductive organ weights, sperm parameters, plasma hormone levels
(FSH, LH and testosterone), testicular and epididymal histo-morphometry and histopathology.
Results: Compared with the normoglycemic animals, hyperglycemic control rats showed reduced weight of the
body and reproductive organ but testis weight was maintained. It was also observed reduction of testosterone and
LH levels, seminiferous tubular diameter, sperm motility and sperm counts in the epididymis. In addition, there was
an increase in morphological abnormalities on spermatozoa as well as in oxidative stress level. Vitamin C reduced
the oxidative stress level, diminished the number of abnormal sperm, and increased testosterone and LH levels and
seminiferous tubular diameter but did not show improvement of sperm motility in relation to the hyperglycemic
control group. Hyperglycemia caused a rearrangement in the epididymal tissue components (stroma, ephitelium
and lumen) as demonstrated by the stereological analysis results. However, this alteration was partially prevented
by vitamin C treatment.
Conclusions: We conclude that vitamin C partially attenuated some male reproductive system dysfunctions in
hyperglycemic rats.
Background
Male sexual dysfunctions are frequently associated with
hyperglycemia in experimental rats [1] and in men [2].
It is well known that in streptozotocin-induced hyper-
glycemic male rats, the reproductive changes include
reduction of male organ and body weights [3,4] oligos-
permia [3,5,6], diminished fertility [7], decreased testos-
terone and gonadotropin levels [6,8] depletion of
spermatogenesis and testicular damage [9,10]. Another
usual consequence of hyperglycemia is the increased
oxidative stress which is extremely toxic to cells and
exerts its devastating effects by directly damaging cellu-
lar proteins, lipids, and DNA, or indirectly, by affecting
normal cellular signaling and gene regulation [11,12].
Vitamin C, or ascorbic acid, is an important antioxi-
dant substance in biological systems [13]. It is a water-
soluble micronutrient, well absorbed by the gastrointest-
inal tract and required for multiple biological functions
and biochemical reactions in humans and animals and it
is an important element for the body [14]. In addition,
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it is an essential nutrient for the biosynthesis of col-
lagen, L-carnitine and norepinephrine. As humans are
unable to synthesize vitamin C, they need this vitamin
in their diet. Thus, prolonged deprivation of vitamin C
generates defects in the post-translational modification
of collagen, followed by illness and eventually death.
Low levels of vitamin C are known to occur in several
pathologies which cause increased oxidative stress, such
as diabetes mellitus, cancer, cataract, HIV infection, and
smoking habits [13]. In the male reproductive system,
vitamin C is known to protect spermatogenesis and it
plays a major role in semen integrity and fertility both
in men [15,16] and animals, increases testosterone levels
[17] and prevents sperm agglutination. It is an impor-
tant chain-breaking antioxidant, contributing up to 65
percent of the total antioxidant capacity of seminal
plasma found intracellulary and extracellulary [18]. Shri-
latha and Muralidhara [19] reported the protective effect
of vitamin C on testicular oxidative stress, sperm oxida-
tive stress and genotoxic effects using a diabetic mice
model. Similarly, Naziroğlu [20] concluded that vitamin
C acted as antioxidant in reproductive milieu. However,
neither these studies nor any other evaluated the effects
of vitamin C on the male reproductive system morpho-
physiology of hyperglycemic adult rats as shown in the
current study.
Therefore, because of the clinical relevance of this mat-
ter and the lack of pertinent information in scientific lit-
erature, the present study aims to ascertain whether
vitamin C could attenuate the damage in male reproduc-
tive system caused by hyperglycemia in adult male rats.
Methods
Animals
Adult male Wistar rats (90 days old) were supplied by
Multidisciplinary Center for Biological Investigation,
State University of Campinas (CEMIB - UNICAMP).
During the experiment, animals were allocated into
polypropylene cages (43 × 30 × 15 cm), with laboratory
grade pine shavings as bedding. Rats were maintained
under controlled temperature (± 23°C) and lighting con-
ditions (12 L, 12D photoperiod, lights switched off at
07:00 am). Rat chow and filtered tap water were pro-
vided ad libitum. Experimental procedures were in
accordance with the Ethical Principles in Animal
Research adopted by the Brazilian College of Animal
Experimentation and were approved by the Biosciences
Institute/UNESP Ethics Committee for Animal Research
(protocol number 022/06).
Experimental design
Hyperglycemic model
Severe diabetes in rats, which reproduces uncontrolled
type 1 diabetes in humans, was chemically induced
using a single dose of 40 mg/kg BW streptozotocin
(SIGMA Chemical Company, St. Louis, MO) injected
into the tail vein of adult male rats (n = 40). Streptozo-
tocin was diluted in citrate buffer 0.01 M, pH = 4.6.
Five days after the induction, glucose levels of all ani-
mals were assessed using glucose test strips and a moni-
toring System (One Touch Ultra, Johnson&Johnson®).
Rats with blood glucose levels higher than 300 mg/dL
were considered to be hyperglycemic, as previous
described by Guneli and colleagues [10]. These animals
were randomly assigned to two experimental groups of
10 animals each: hyperglycemic control (Hy) and hyper-
glycemic + 150 mg/day of vitamin C (HyC). This dose
was adapted from Naziroğlu [20]. Another animal group
(n = 10) received no streptozotocin (normoglycemic
group = N group) and presented glycemic levels lower
than 100 mg/dL. The vitamin C-treated hyperglycemic
rats received the vitamin by gavage (oral route) through-
out 30 consecutives days. Normoglycemic and hypergly-
cemic control groups received only the vehicle (water)
during the same period. This period of treatment was
chosen based on previous studies from our laboratory in
which we observed that the hyperglycemic animals were
not so weak until this period, which could interfere with
the analysis of the reproductive system. The work was
divided into two studies, denominated Experiment 1 and
Experiment 2, described as follows.
Preparation of vitamin C
Vitamin C (L-Ascorbic acid; SIGMA-ALDRICH, St.
Louis, MO, USA) was prepared daily by diluting the
required quantity in the corresponding volume of warm
water and stored in a dark container to protect against
light.
Experiment 1
Body weight and weight of some reproductive organs
At the end of the treatment, rats (without fasting) were
slightly anesthetized with sodium pentobarbital (0.1 mL/
kg weight - Hypnol® 3%; SYNTEC, São Paulo, Brazil),
weighed and killed by decapitation. Blood was collected
(between 9:00 and 11:30 am) from the ruptured cervical
vessels for determination of sexual hormones and oxida-
tive stress levels. The right testis and epididymis, ventral
prostate and seminal vesicle (without the coagulating
gland and full of secretion) were removed and their
weights (absolute and relative to body weights) were
determined. Testis and epididymis were used for sperm
counts.
Oxidative stress status assay
Blood was collected into anticoagulant tubes (Liquemine
- Hoffman-La Roche, Switzerland) and was centrifuged
at 90 g for 10 minutes at room temperature for assay of
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oxidative stress status. Hemoglobin levels were ana-
lyzed to calculate final values of oxidative stress bio-
markers: SOD (superoxide dismutase), GSH-t (total
glutathione), glutathione peroxidase (GSH-Px) and
TBARS (thiobarbituric acid reactive species) [21]. All
these biomarkers were estimated in the washed ery-
throcytes. Briefly 1.0 mL of washed erythrocytes were
added to the test tube containing 1.0 mL of 3.0% sul-
phosalicylic acid, agitated for 10 seconds, centrifuged
at 11.000 rpm for 3 minutes and rested for 15 minutes.
The sample was diluted to 500 μl of 0.67% TBA solu-
tion (Thiobarbituric acid; SIGMA, St. Louis, USA).
The mixture was heated to 80°C for 30 minutes and its
absorbance measured at a wavelength 535 nm. The
results were expressed as nmol of TBARS per gram of
hemoglobin (nmol/g Hb), and TBARS was evaluated as
an index of lipid peroxidation [21].
Superoxide dismutase (SOD) activity was determined
from its ability to inhibit the auto-oxidation of pyrogallol
(Pyrogallic acid; Synth® , Diadema, Brazil). The reaction
mixture (1.0 mL) consisted of 5.0 mmol/L Tris (hydroxy-
methyl) aminomethane (pH 8.0), 1.0 mmol/L EDTA,
bidistilled water and 20 μL of the sample. The reaction
was initiated by the addition of pyrogallol (final concen-
tration of 0.2 mmol/L), and the absorbance was mea-
sured by a spectrophotometer with a wavelength of 420
nm (25°C) for 5 minutes. Enzymatic activity unit was
defined as SOD units able to produce 50% of pyrogallol
oxidation inhibition. All data were expressed in units of
SOD per milligram of hemoglobin (UI/mg Hb) [21].
Glutathione total content (GSHt), which consists of
reduced and oxidized glutathiones, was enzymatically
determined using 5,5’-dithiobis-2-nitrobenzoic acid
(DTNB; SIGMA, St. Louis, USA) and glutathione reduc-
tase in the presence of NADPH, forming 2-nitro-5-thio-
benzoic acid. A mixture consisting of 1290 μL of
distilled water, 200 μL of Tris/HCl buffer (1 mol/L,
pH8.0; 5 mmol/L EDTA), 200 μL of 10 UI/mL glu-
tathione reductase (GSH-r; SIGMA, St. Louis, USA),
200 μL of 2 mmol/L NADPH (SIGMA, St. Louis, USA)
and 100 μL of 12 mmol/L of DTNB (SIGMA, St. Louis,
USA) was added to 10 μL of the sample. Activity was
measured at 412 nm on a spectrophotometer. One unit
of activity was equal to micromolar of substrate reduced
per gram of hemoglobin (μmol/g Hb)[21].
Glutathione peroxidase enzyme activity (GSH-Px) was
measured by NADPH oxidation assay. The mixture con-
sisted in the addition of 1300 μL of distilled water, 200
μL of Tris/HCl buffer (EDTA 1 mol/L; pH 8.0; 5 mmol/
L), 200 μL of 10 UI/mL of glutathione reductase (GSH-
Rd; SIGMA, St. Louis, USA), 200 μL of NADPH
(2 mmol/L), 40 μL of GSH (0.1 mol/L) to 40 μL of
hemolysate. The mixture was agitated in a vortex mixer
for 10 seconds. Next, 20 μL of T-butyl hydroperoxide
(7 mmol/L) were added and maintained at 37°C for 10
minutes. Absorbance was determined by a spectrophot-
ometer with a wavelength of 340 nm. GSH-Px activity
was expressed in enzymatic activity units per gram of
hemoglobin (UI/g Hb) [21].
Plasma testosterone, LH and FSH levels
Blood was collected into anticoagulant tubes (Lique-
mine - Hoffman-La Roche, Switzerland) and was used
to determine plasma testosterone, luteinizing hormone
(LH) and follicle-stimulating hormone (FSH) levels.
The plasma was obtained by centrifugation (2400 rpm,
for 20 minutes at 3.5°C) in a refrigerated centrifuge
and was frozen at -20°C until the moment of hormonal
determination. The analyses were determined by the
technique of double antibody radioimmunoassay at the
Neuroendocrinology Laboratory, Dental School of Uni-
versity of São Paulo - USP campus at Ribeirão Preto,
Sao Paulo state, Brazil. Testosterone doses were
accomplished by using the TESTOSTERONE MAIA®
kit (Biochem Immuno System). The LH and FSH doses
used specific kits supplied by the National Institute of
Arthritis, Diabetes and Kidney Diseases (NIADDK,
USA). All samples were dosed in the same assay to
avoid inter-assay errors. The lowest detection limits
and intra-assay errors for FSH, LH and testosterone
were respectively: 0.09, 0.04 and 0.064 ng/mL and 2.8,
3.4 and 4.0%.
Daily sperm production per testis, sperm number and
transit time in the epididymis
Homogenization-resistant testicular spermatids (stage 19
of spermiogenesis) in the testis were counted as
described previously by Robb et al. [22], with adapta-
tions adopted by Fernandes et al. [23]: briefly, the right
testis, decapsulated and weighed soon after collection,
was homogenized (T18 Ultra Turrax® Homogenizer -
IKA® Labortechnik, Germany) in 5 mL of NaCl 0.9%
containing TritonX100 0.5% (SIGMA, St. Louis, USA),
followed by sonication (U50 control, ultra sonic proces-
sor - IKA® Labortechnik, Germany) for 30 seconds.
After a 10-fold dilution, one sample was transferred to
Newbauer chambers (Neubauer improved, bright line -
LABOROPTIK) and late spermatids were counted (four
fields per animal). To calculate daily sperm production
(DSP), the number of homogenization-resistant sperma-
tids was divided by 6.1 (the number of days these sper-
matides are present in the seminiferous epithelium). In
the same manner, right epididymidis portions (caput/
corpus and cauda) were cut into small fragments with
scissors and homogenized, and sperm counted as
described for the testis. The sperm transit time through
the epididymis was determined by dividing the number
of sperm in each portion by DSP.
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Sperm morphology
Sperm were removed from the right vas deferens by
internal rinsing with 1.0 mL of saline formol, with the
aid of a syringe and needle. To analyze sperm morphol-
ogy, smears were prepared on histological slides that
were left to dry for 90 minutes and observed in a phase-
contrast microscope (Leica DMLS) at 400× magnifica-
tion [24]. One hundred spermatozoa were analyzed per
animal. Morphological abnormalities were classified into
two general categories pertaining to head morphology
(without curvature, without characteristic curvature, or
isolated form, i.e., no tail attached) and tail morphology
(broken, isolated, i.e., no head attached, or rolled into a
spiral [25]. This analysis was performed as described by
Fernandes and colleagues [23].
Experiment 2
Other 30 animals were randomly assigned to three
groups (n = 10/group) following the same experimental
protocol described for Experiment 1.
Morphometric and histopathological analyses
The left testis and epididymis (five per experimental
group) were removed and fixed in an Alfac fixing solu-
tion (80% ethanol, formaldehyde and glacial acetic acid,
8.5:1.0:0.5 v/v) for 24 h. The pieces were embedded in
paraffin wax and sectioned at 7 μm. Testis and epididy-
mis sections were stained with hematoxylin and eosin
(HE) and examined by light microscopy for general his-
topathological and morphometric analysis as follows:
Seminiferous tubule diameters
Seminiferous tubule diameters were measured using Leica
Q-win software (version 3 for Windows™). For this, 10
random testicular cross-sections (stage IX of the semini-
ferous epithelium cycle) per animal were examined blindly
at 2007× magnification in a Leica microscope DMLB. In
each seminiferous tubule the mean of four measures was
calculated and used in the statistical analysis.
Spermatogenesis kinetics
Two hundred random tubular sections per animal in
three nonconsecutive testis cross-sections were classified
into four categories: stages I-VI, VII-VIII, IX-XIII and
XIV of the seminiferous epithelium cycle, according to
Leblond and Clemont [26], under a light microscope
(Zeiss, Axiostar plus) at 200X magnification.
Epididymal stereological analysis
The stereological analysis of the epididymis was mea-
sured using Leica Q-win software (version 3 for Win-
dows™) and a Leica microscope DMLB (200×
magnification). For this, 10 random epididymal cross-
sections per animal were captured and analyzed by the
stereological method. This analysis was performed by
means of Weibel’s multipurpose graticulate, with 120
points and 60 test lines [27] to compare the relative
proportion among the epididymal components (epithe-
lium, stroma and lumen) in the experimental groups.
Sperm motility
Sperm were obtained, from the right vas deferens, with the
aid of a syringe and needle, through internal rinsing with
1.0 mL of modified HTF medium with gentamicin
(Human Tubal Fluid, IrvineScientific®), at 34°C. A Makler
counting chamber (Sefi-Medical, Haifa, Israel) warmed to
34°C was loaded with a small aliquot of sperm solution
(10 μl). Sperm motility evaluation was performed by the
same person throughout the study and was assessed by
visual estimation (100 spermatozoa per animal, in dupli-
cate) under a phase-contrast microscope (Leica DMLS) at
200× magnification. Spermatozoa were classified as:
mobile with progressive movement, mobile without pro-
gressive movement or immobile. This analysis was per-
formed as described by Perobelli and colleagues [28].
Statistics
The variance among the experimental groups was com-
pared by ANOVA, with the post hoc Tukey test or the
non-parametric Kruskall-Wallis test, with the post hoc
Dunn test, according to the dada distribution. Differ-
ences were considered significant when p < 0.05. The
statistical analyses were performed by GraphPad InStat
(version 3.02).
Results
Glycemia levels and animal health
In both experiments, five and ten days after the hyper-
glycemia induction, all streptozotocin-treated animals
showed glycemic levels above 300 mg/dL and were,
therefore, considered hyperglycemic. These animals
exhibited characteristic qualitative signs of hyperglyce-
mia such as polyphagia, polydipsia and polyuria (data
not shown). The normoglycemic rats showed normal
glycemic levels, below 100 mg/dL. These glycemic sta-
tuses were maintained throughout the experimental per-
iod (Figure 1). Some hyperglycemic animals died during
experimental period (Experiment 1 = one animal from
vitamin C-treated hyperglycemic group; Experiment 2 =
one animal from each hyperglycemic group)
Oxidative stress analysis
In relation to oxidative stress analysis on erythrocytes
(Table 1), the lipid peroxidation level (TBARS) was sig-
nificantly increased in the hyperglycemic control group
in relation to the other groups. The treatment with vita-
min C reduced this damaging event. The hyperglycemic
control group showed higher SOD activity compared to
the other groups. This enzymatic activity was recovered
by vitamin C in the hyperglycemic rats. Concentrations
of GSHt were similar between hyperglycemic control
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and normoglycemic groups but these concentrations in
the vitamin C-treated hyperglycemic group were signifi-
cantly increased in relation to the other groups. There
was a decrease of the GSH-Px activity in the hyperglyce-
mic control group in relation to the other groups. The
activity of this enzyme was maintained in the vitamin C-
treated hyperglycemic rats and it was similar to the nor-
moglycemic group.
Body and reproductive organ weights
Body and reproductive organ weights are shown in Table
2. Streptozotocin-induced hyperglycemia produced a
significant decrease in the final body, prostate and full
seminal vesicle weights compared to normoglycemic ani-
mals. However, the absolute testicular and relative epidi-
dymal weights were similar among the three groups, and
relative weight of ventral prostate was partially recovered
in the vitamin C-treated group. There was an increase in
the testis relative weight of the two hyperglycemic groups
probably due to the reduced body weights of these
animals.
Hormonal analysis
The FSH levels were unaffected by hyperglycemia. There
was a significant reduction in plasma testosterone and
LH levels in the hyperglycemic control group. However,
in the vitamin C-treated hyperglycemic group, androgen
and LH levels were partially recovered (Table 3).
Sperm parameters
The three groups didn’t differ in relation to daily sperm
production, frequency of spermatogenesis stages, abso-
lute number of sperm and sperm transit time in the
caput/corpus epididymis (data not shown). Compared to
normoglycemic group, the hyperglycemic control group
presented lower absolute number of sperm (millions/
epididymis) and transit days in the cauda epididymis
indicating an acceleration of the sperm transit time
through epididimal cauda. In the vitamin C-treated
group these parameters were similar to the other groups
(Table 4).
Morphology assessment of spermatozoa (Table 5)
indicated that the abnormal percentages in sperm were
higher in the hyperglycemic groups (Hy = 35%, HyC =
23%) compared to the normoglycemic group (9%). Vita-
min C partially recovered the sperm morphology since
the number of sperm with head without curvature was
totally recovered and the number of sperm with isolated
head and isolated tail was partially recovered by the
treatment with vitamin C. The other abnormalities, as
described in the methodology, were not found.
The results of sperm motility, shown in Table 6, indi-
cated that the number of sperm with progressive move-
ment was reduced and the number of immobile sperm
was increased in the hyperglycemic groups compared to
the normoglycemic group. Comparing with the normo-
glycemic group, the treatment with vitamin C
Figure 1 Blood glycemic levels from Experiment 1 (A) and
Experiment 2 (B). Values expressed as mean and S.E.M (vertical
bars). Kruskal-Wallis with post hoc Dunn test; * p < 0.05 =
Hyperglycemic groups compared with normoglycemic group. N =
normoglycemic group; Hy = hyperglycemic control group; HyC =
hyperglycemic group + vitamin C.
Table 1 Blood biomarkers of oxidative stress
Groups Normoglycemic
(n = 10)
Hyperglycemic
(n = 10)
Hyperglycemic + vitamin C
(n = 9)
TBARS (nmol/g Hb) 39.04 [32.82 - 52.82]a 456.78 [391.30 - 630.00]b 96.60 [75.02 - 132.20]a
SOD (UI/mg Hb) 1842.80 [1434.73 - 3481.02] a 3929.30 [3687.09 - 5044.50] b 2000.00 [1603.20 - 2257.96]a
GSHt (μmol/g Hb) 0.05 [0.04 - 0.07] a 0.08 [0.04 - 0.12] a 0.29 [0.23 - 0.33] b
GSH-Px (UI/g Hb) 0.33 [0.28 - 0.65] a 0.02 [0.01 - 0.09] b 0.13 [0.13 - 0.16] a
Values expressed as median [Q1 - Q3].
a, b Different letters indicate groups that differ statistically (p < 0.05). Kruskal - wallis test, with the post hoc Dunn test.
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diminished this damage since in the hyperglycemic con-
trol group the incidence of immobile sperms was more
significant (p < 0.001) than in the group treated with
vitamin C (p < 0.05).
Seminiferous tubular diameters, histopathology and
epididymal stereological analysis
The seminiferous tubular diameters were significantly
smaller in hyperglycemic control rats (Hy = 288.41 ±
3.70 - p < 0.05) in relation to the normoglycemic group
(N = 303.00 ± 4.01); in the vitamin C-treated group
(HyC = 295.50 ± 4.00) this parameter was considered
similar to the other two groups.
However, the histopathology of the testis and epididy-
mis (data not shown) was not affected by hyperglycemia
or hyperglycemia plus vitamin C. In the testis, the sper-
matogenic cells, Sertolli cell and the arrangement of the
seminiferous epithelium were structurally normal in the
experimental groups. The Leydig cells and interstitial
connective tissue seemed to be uniform in size and
shape in the three groups. In the epididymis, the stromal
and ephithelial tissues appeared to be normal, as well as
in the lumen which showed only sperms.
The epididymal stereological analysis (Table 7) showed a
significant increase of epididymal stromal compartment in
animals from the hyperglycemic control group compared
to normoglycemic rats, but there was a complete recovery
of this compartment in the group treated with vitamin C.
In both hyperglycemic groups, the epididymal duct epithe-
lium was higher than in normoglycemic animals. This ana-
lysis also revealed a significant decrease in the epididymal
luminal compartment in the hyperglycemic control group
compared to normoglycemic group, but it was also totally
recovered in the vitamin C-treated rats.
Discussion
As previously showed [29], our study demonstrated that
oral administration of vitamin C produced an antioxi-
dant effect in the erythrocytes, as evidenced by signifi-
cant increase of GSHt concentration and GSH-Px
activity, and reduced TBARS levels in streptozotocin-
induced hyperglycemia in rats. These results showed
that oxidative stress level was reduced and also provided
evidence that vitamin C may have a therapeutic role in
reactive oxygen species mediated diseases.
We can suggest that the reduction of oxidative stress
in the erythrocytes may also have occurred in the organs
of male reproductive system and sperm, since previous
studies reported that vitamin C attenuated concomi-
tantly the oxidative stress in different tissues of hyper-
glycemic rats [29,30]. Thus, further studies with the
same experimental design of the present study should
be conducted to confirm this hypothesis.
Reductions of body, testicular, epididymal and prostate
weights, shown in this study, have already been
described in hyperglycemic animals [1,3,5] and can be
related to the hormonal and metabolic changes that are
found in hyperglycemic animals and human beings. In
rats, under hyperglycemic conditions, the insulin repla-
cement restores body and reproductive organ weights,
but prostate weight can only be restored by testosterone
therapy [31].
Table 2 Reproductive organs and body weights
Normoglycemic
(n = 10)
Hyperglycemic
(n = 10)
Hyperglycemic + vitamin C
(n = 9)
Initial BW (g) 366.00 ± 7.75 a 365.00 ± 5.80 a 366.80 ± 11.26 a
Final BW (g) 417.40 ± 9.02 a 303.40 ± 9.80 b 303.44 ± 7.27 b
Testis (g)
Testis (g/100 g)
1.80 ± 0.05 a
0.43 ± 0.01 a
1.64 ± 0.05 a
0.54 ± 0.01 b
1.63 ± 0.06 a
0.54 ± 0.01b
Epididymis (mg)
Epididymis (mg/100 g)
569.84 ± 13.33 a
137.00 ± 3.70 a
417.80 ± 26.37 b
137.00 ± 6.11 a
436.11 ± 20.90 b
143.32 ± 4.60 a
Seminal vesicle full (g)
Seminal vesicle full (g/100 g)
1.37 ± 0.07 a
0.32 ± 0.02 a
0.54 ± 0.12 b
0.14 ± 0.02 b
0.58 ± 0.10 b
0.15 ± 0.04 b
Ventral prostate (mg)
Ventral prostate (mg/100 g)
418.91 ± 18.50 a
97.61 ± 4.80 a
198.87 ± 19.62 b
64.82 ± 5.65 b
239.38 ± 26.64 b
77.81 ± 7.31 ab
Values expressed as Mean ± SEM. a, b Different letters indicate groups that differ statistically (p < 0.05). ANOVA test, with the post hoc Tukey test.
Table 3 Hormone analysis
Groups Normoglycemic
(n = 10)
Hyperglycemic
(n = 10)
Hyperglycemic + vitamin C (n = 9)
Testosterone (ng/mL) 1.65 [1.60 - 1.77] a 0.32[0.15 - 0.85] b 0.48[0.26 - 1.20] ab
LH (ng/mL) 6.60[5.20 - 10.04] a 3.03 [2.45 - 4.03] b 3.60[2.75 - 4.21] ab
FSH (ng/mL) 6.70[4.90 - 8.61] a 5.30 [4.04 - 8.41] a 7.10 [6.62 - 7.40] a
Values expressed as median [Q1 - Q3].
a, b Different letters indicate groups that differ statistically (p < 0.05). Kruskal - Wallis test, with the post hoc Dunn test.
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It is known that vitamin C plays key roles in the
synthesis of testosterone [17,32] and in our study vita-
min C-treated hyperglycemic rats showed partial recov-
ery of testosterone level but it was not enough to
prevent the loss of ventral prostate or seminal vesicle
absolute weights. In this same group the ventral prostate
relative weight was partially restored probably due to
changes in body weight. In the present study, the
reduced LH level corroborates previous studies that
reported diminished LH release from pituitary gland in
hyperglycemic male rats [6,33]. The partial recovery of
LH levels in the vitamin C treated group may be related
to the fact that ascorbic acid can be a vitaminergic
transmitter that activates the release of LH and FSH
from the anterior pituitary gland [34]. Although FSH
levels were not reduced in the hyperglycemic rats, the
normal levels of this hormone are in accordance with
the sperm counts in testis and the frequencies of sper-
matogenesis stages. However, plasma levels of FSH were
reduced in hyperglycemic rats [33] and diabetic patients
[35].
Despite changes in testosterone levels in the hypergly-
cemic groups, the testicular weight, frequency of sper-
matogenesis kinetics and the daily sperm production
were not affected. However, Hassan and colleagues [5]
reported the reduced sperm number in the testis in dia-
betic rats, after six weeks of streptozotocin-induced
hyperglycemia. The reduction of seminiferous tubular
diameter corroborates other authors that also found this
impairment in streptozotocin-induced hyperglycemia
after three [36] and twenty days [10], or six weeks [1,37]
and six months [9]. In contrast, Ballester and colleagues
[38] reported similarity in the seminiferous tubular dia-
meters in hyperglycemic and normoglycemic rats, after
Table 4 Sperm counts in the epididymis
Groups Normoglycemic
(n = 10)
Hyperglycemic
(n = 10)
Hyperglycemic + vitamin C (n = 9)
Sperm number in the cauda epididymis (×106) 111.00 [90.00 - 131.00] a 40.16 [33.05 - 71.00] b 43.00 [42.63 - 73.80] ab
Sperm transit time in the cauda (days) 3.43 [3.30 - 4.65] a 1.56 [1.25 - 2.70] b 2.14 [1.72 - 2.88] ab
Values expressed as median [Q1 - Q3].
a, b Different letters indicate groups that differ statistically (p < 0.05). Kruskal - Wallis test, with the post hoc Dunn test.
Table 5 Sperm morphology
Groups Normoglycemic
(n = 10)
Hyperglycemic
(n = 10)
Hyperglycemic + vitamin C (n = 9)
Head isolated 4.70 ± 0.52 a 20.00 ± 3.60 b 14.00 ± 2.60 ab
Head without curvature 1.40 ± 0.30 a 3.80 ± 0.73 b 1.30 ± 0.36 a
Tail isolated 2.30 ± 0.65 a 11.00 ± 3.06 b 7.71 ± 1.15 ab
Normal sperm 91.30 ± 1.03 a 65.30 ± 5.05 b 77.30 ± 2.24 b
Values expressed as mean ± SEM. a, b Different letters indicate groups that differ statistically (p < 0.05). ANOVA test, with the post hoc Tukey test.
Table 6 Sperm motility
Groups Normoglycemic
(n = 10)
Hyperglycemic
(n = 9)
Hyperglycemic + vitamin C (n = 9)
Mobile with progressive movement 68.4 [64.25 - 69.75] a 36.2 [28 - 46] b 35 [17.25 - 51.75] b
Mobile without progressive movement 8.5 [7 - 12.5] a 6.0 [4 - 12] a 9.0 [5.75 - 25.5] a
Immobile sperm 22.1 [19.25 - 24.5] a 56.3 [46 - 65] b 47.5 [38.75 - 50.25] b
Values expressed as median [Q1 - Q3].
a, b Different letters indicate groups that differ statistically (p < 0.05). Kruskal - Wallis test, with the post hoc Dunn test.
Table 7 Epididymal stereological analysis
Experimental groups
Normoglycemic Hyperglycemic Hyperglycemic + vitamin C
Cauda epididymis (region 6A)
Stroma 15.75 [10.71 - 22.17] a 23.51 [20.39 - 26.80] b 14.30 [11.01 - 20.10] a
Epithelium 14.28 [11.16 - 17.85] a 20.24 [16.82 - 22.02] b 19.64 [17.41 - 23.00] b
Lumen 67.86 [64.29 - 75.16] a 56.25 [48.51 - 62.65] b 63.10 [58.63 - 70.24] a
N = 50 histological fields/group. Values expressed as Median (Q1 - Q3).
a, b indicate statistically different results (p < 0.05). Kruskal - Wallis test, with the post hoc
Dunn test.
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three months of streptozotocin-induced hyperglycemia.
Vitamin C attenuated the reduction of seminiferous tub-
ular diameters probably because this vitamin may have
acted in the synthesis of extracellular matrix compo-
nents, as previously reported [13,14], although high glu-
cose concentration inhibits the action of vitamin C on
collagen and proteoglycans synthesis [39]. It is impor-
tant to realize that, there is a wide variation in the
development of significant testicular atrophy among
diabetic rats depending on the route of streptozotocin-
administration, dose, degree of hyperglycemia, testoster-
one levels and most important, sampling time. Based on
these arguments, the absence of testicular histopatholo-
gycal alterations may be explained, since previous
studies reported histopathologycal changes in the testis
[10,36,40] only after longer periods of spontaneous or
streptozotocin-induced hyperglycemia. However, in
short periods of hyperglycemia (15 days) such testicular
alterations were not observed [3].
The decrease in absolute weight of epididymis in the
hyperglycemic groups was related to a significant accel-
eration of the sperm transit time caused by the decrease
in sperm reserves in the epididymal cauda, and by a rear-
rangement of the tissue components as demonstrated by
the stereological analyze. Scarano and colleagues [3]
reported epididymal oligospermia in streptozotocin-
induced hyperglycemia and Sönmez and colleagues [17]
showed that epididymal sperm concentration increased
in the ascorbic acid treated rats, as evidenced in the cur-
rent study. Soundamani and colleagues [41] reported that
the streptozotocin-induced hyperglycemia in prepubertal
rats (40 days old), caused epididymal regression in pub-
erty (61st day of postnatal life), leading to a decrease in
the absolute weights of caput, corpus, and caudal regions,
and a considerable reduction in tubule and lumen sizes
of these segments with an increase in interstitial stroma.
In the present study, despite these stereological altera-
tions there were no histopathological changes, corrobor-
ating previous study from our lab [3]. The regression in
epididymal tissue was attenuated in the vitamin C-trea-
ted hyperglycemic group. Thus, it is quite likely that
vitamin C may have specific effect on epididymal tissue.
However, the mechanisms, through which vitamin C
influences this tissue, are not known and there are no
previous studies on this subject.
Hyperglycemic rats showed impairment in sperm mor-
phology corroborating a study of Navarro-Casado et al.,
[37], and some of the abnormalities were attenuated by
vitamin C treatment. This result may suggest that vita-
min C could have an effect on spermiogenesis process
and it could favor, at least partially, normal sperm pro-
duction. The impairment in sperm motility caused by
hyperglycemia also corroborated previous studies
[5,7,37] but this damaged is not prevented by vitamin C.
It is known that vitamin C increases gamete mobility
since it reduces oxidative stress level [42]. Donnelly and
colleagues [43] showed that ascorbate supplementation
reduced oxidative stress, but it was not beneficial to
sperm motility in human semen.
Conclusions
In conclusion, the present study showed that vitamin C
supplementation minimized some alterations in the
male reproductive system caused by hyperglycemia such
as reduction of testosterone and LH levels and impair-
ment in sperm morphology. However, questions about
vitamin supplementation, or any other nutrient, have
been asked since excessive doses can be harmful to the
body. Thus, it is possible that the beneficial effects of
vitamin C supplementation are only relevant to those
individuals with low levels of vitamin C and high levels
of oxidative stress that occur in hyperglycemic condi-
tion. Thus, future studies are needed to complement the
findings of this study.
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